Comparing symptoms and emotion recognition in African American and White samples with schizophrenia

Racial status has an important role in schizophrenia, with African American samples being rated lower than White participants on a range of constructs. In many studies, however, demographic factors are not accounted for. In the present study, African American (n = 106) and White participants (n = 81) were compared on symptom severity and emotion recognition scales while controlling for other demographic factors. Contrary to our hypothesis, there were no differences in symptoms between racial groups. However, White participants performed better on an emotion recognition measure than African Americans. These differences were most prominent in response to negatively-valenced stimuli. This study replicated previous findings of racial differences in emotion recognition but not symptom severity. Future research should assess the role of racial identity on symptom severity. In addition, further research is needed to assess if utilising multi-ethnic stimuli improves performance by racial minorities on emotion recognition measures

The association of multidimensional schizotypy with symptoms and impairment across racial groups

First published online: 15 September 2021The assessment of schizotypy and schizophrenia-spectrum psychopathology has historically been adversely impacted by multiple forms of measurement bias, including racial bias. The Multidimensional Schizotypy Scale (MSS) was developed using modern scale construction methods to minimize measurement bias in the assessment of schizotypic traits. However, studies have not examined the validity of the measurement across different racial groups. The present study examined whether the associations of MSS positive, negative, and disorganized schizotypy subscales with interview-assessed ratings of functioning, schizophrenia-spectrum personality traits, and depressive disorders were generally comparable across nonclinically ascertained samples of Black (n = 46), Asian (n = 87), and White (n = 116) young adults. Consistent with previous findings, all three schizotypy subscales were associated with impairment and schizotypal and paranoid traits. Negative schizotypy was associated with schizoid traits, and disorganized schizotypy was associated with depressive disorders. These associations were comparable across the racial groups, supporting the use of the MSS in these groups. Culturally and empirically valid assessments are essential for providing accurate assessments across racial/ethnic groups and reducing the risk of overpathologizing people of color. The present findings support the cross-cultural validity of the MSS; however, future studies should expand upon these findings by including more diverse samples and longitudinal designs